{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:07:41Z","timestamp":1780697261938,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s10620-005-2960-7","type":"journal-article","created":{"date-parts":[[2005,9,26]],"date-time":"2005-09-26T07:59:42Z","timestamp":1127721582000},"page":"1909-1915","source":"Crossref","is-referenced-by-count":38,"title":["The Value of Ambulatory 24 hr Esophageal pH Monitoring in Clinical Practice in Patients Who Were Referred with Persistent Gastroesophageal Reflux Disease (GERD)-Related Symptoms While on Standard Dose Anti-Reflux Medications"],"prefix":"10.1007","volume":"50","author":[{"given":"Jimmy M.","family":"Bautista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-man","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Pulliam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romeo F.","family":"Esquivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie","family":"Fass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"2960_CR1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archinte.159.7.649","volume":"159","author":"RH Hunt","year":"1999","unstructured":"Hunt RH: Importance of pH control in the management of GERD. Arch Intern Med 159:649\u2013657, 1999","journal-title":"Arch Intern Med"},{"key":"2960_CR2","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1053\/gast.2001.24841","volume":"120","author":"D Sifrim","year":"2001","unstructured":"Sifrim D, Holloway R, Silny J, Xin Z, Tack J, Lerut A, Janssens J: Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24 hr pH-impedance recordings. Gastroenterology 120:1862\u20131864, 2001","journal-title":"Gastroenterology"},{"key":"2960_CR3","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/gast.2001.24840","volume":"120","author":"MF Vela","year":"2001","unstructured":"Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO: Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 120:1599\u20131606, 2001","journal-title":"Gastroenterology"},{"key":"2960_CR4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0953-0673.2004.01835.x","volume":"19","author":"J Tack","year":"2004","unstructured":"Tack J, Fass R: Approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder? Aliment Pharmacol Ther 19:28\u201334, 2004","journal-title":"Aliment Pharmacol Ther"},{"key":"2960_CR5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0889-8553(02)00046-8","volume":"31","author":"R Fass","year":"2002","unstructured":"Fass R: Gastroesophageal reflux disease revisited. Gastroenterol Clin North Am 31:S1\u2013S10, 2002","journal-title":"Gastroenterol Clin North Am"},{"key":"2960_CR6","first-page":"1527","volume":"91","author":"LP Leite","year":"1996","unstructured":"Leite LP, Johnston BT, Just RJ, Castell DO: Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 91:1527\u20131531, 1996","journal-title":"Am J Gastroenterol"},{"key":"2960_CR7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2036.1990.tb00495.x","volume":"4","author":"EC Klinkenberg-Knol","year":"1990","unstructured":"Klinkenberg-Knol EC, Meuwissen SG: Combined gastric and oesophageal 24 hr pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole. Aliment Pharmacol Ther 4:485\u2013495, 1990","journal-title":"Aliment Pharmacol Ther"},{"key":"2960_CR8","doi-asserted-by":"crossref","unstructured":"Savarino V, Mela GS, Zentilin P, Celle G: Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease? Gastroenterology 99, 1990","DOI":"10.1016\/0016-5085(90)91211-N"},{"key":"2960_CR9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00042737-199802000-00004","volume":"10","author":"R Carlsson","year":"1998","unstructured":"Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, Haug K, de Groot G, van Oudvorst A, Dalvag A, Junghard O, Wiklund I: Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 10:119\u2013124, 1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2960_CR10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1572-0241.2001.03511.x","volume":"96","author":"R Fass","year":"2001","unstructured":"Fass R, Fennerty MB, Vakil N: Nonerosive reflux disease\u2014current concepts and dilemmas. Am J Gastroenterol 96:303\u2013314, 2001","journal-title":"Am J Gastroenterol"},{"key":"2960_CR11","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0002-9270(03)00009-1","volume":"98","author":"R Fass","year":"2003","unstructured":"Fass R: Epidemilogy and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 98:S2\u2013S7, 2003","journal-title":"Am J Gastroenterol"},{"key":"2960_CR12","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1053\/gast.1996.1101982","volume":"110","author":"PJ Kahrilas","year":"1996","unstructured":"Kahrilas PJ, Quigley EM: American Gastroenterological Association Medical Position Statement: guidelines on the use of esophageal pH recording. Gastroenterology 110:1981\u20131996, 1996","journal-title":"Gastroenterology"},{"issue":"108","key":"2960_CR13","first-page":"S38","volume":"98","author":"R Dekel","year":"2003","unstructured":"Dekel R, Malagon IB, Green C, Fass R: Abstract: Comparison of transnasaly placed wireless pH capsule (BRAVO) versus traditional 24 hr esophageal pH monitoring\u2014A randomized trial. Am J Gastroenterol 98(108):S38, 2003","journal-title":"Am J Gastroenterol"},{"key":"2960_CR14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/BF01535789","volume":"33","author":"GJ Wiener","year":"1988","unstructured":"Wiener GJ, Morgan TM, Copper JB, Wu WC, Castell DO, Sinclair JW, Richter JE: Ambulatory 24 hr esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 33:1127\u20131133, 1988","journal-title":"Dig Dis Sci"},{"key":"2960_CR15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF01297020","volume":"36","author":"JE Richter","year":"1991","unstructured":"Richter JE, Hewson EG, Sinclair JW, Dalton CB: Acid perfusion test and 24 hr esophageal pH monitoring with symptom index. Comparison of tests for esophageal acid sensitivity. Dig Dis Sci 36:565\u2013571, 1991","journal-title":"Dig Dis Sci"},{"key":"2960_CR16","first-page":"358","volume":"83","author":"GJ Wiener","year":"1988","unstructured":"Wiener GJ, Richter JE, Copper JB, Wu WC, Castell DO: The symptom index: a clinically important parameter of ambulatory 24 hr esophageal pH monitoring. Am J Gastroenterol 83:358\u2013361, 1988","journal-title":"Am J Gastroenterol"},{"key":"2960_CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gut.37.1.7","volume":"37","author":"KC Trimble","year":"1995","unstructured":"Trimble KC, Pryde A, Heading RC: Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 37:7\u201312, 1995","journal-title":"Gut"},{"issue":"128","key":"2960_CR18","first-page":"A-18","volume":"4","author":"A Hobson","year":"2004","unstructured":"Hobson A, Matthews P, Furlong P, Qasim A: Abstract: The role of esophageal afferent pathway sensitivity in non-erosive reflux disease. Gastroenterology 4(128):A-18, 2004","journal-title":"Gastroenterology"},{"key":"2960_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(78)90020-9","volume":"5","author":"RH Gracely","year":"1978","unstructured":"Gracely RH, McGrath P, Dubner R: Ratio scales of sensory and affective verbal pain descriptors. Pain 5:5\u201318, 1978","journal-title":"Pain"},{"key":"2960_CR20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0016-5085(97)70220-8","volume":"112","author":"DH Silverman","year":"1997","unstructured":"Silverman DH, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA: Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 112:64\u201372, 1997","journal-title":"Gastroenterology"},{"key":"2960_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00003495-200464030-00004","volume":"64","author":"R Dekel","year":"2004","unstructured":"Dekel R, Morse C, Fass R: The role of proton pump inhibitors in gastro-oesophageal reflux disease. Drugs 64:277\u2013295, 2004","journal-title":"Drugs"},{"key":"2960_CR22","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","volume":"112","author":"N Chiba","year":"1997","unstructured":"Chiba N, De Gara CJ, Wilkinson JM, Hunt RH: Speed of healing and symptom relief in grade II and IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 112:1798\u20131810, 1997","journal-title":"Gastroenterology"},{"issue":"640","key":"2960_CR23","first-page":"A-82","volume":"126","author":"MF Vaezi","year":"2004","unstructured":"Vaezi MF, Charbel S: Abstract: On-therapy pH monitoring: usually recommended but should we do it? Gastroenterology 126(640):A-82, 2004","journal-title":"Gastroenterology"},{"issue":"132","key":"2960_CR24","first-page":"A-19","volume":"126","author":"AH Levy","year":"2004","unstructured":"Levy AH, Benwait KS, DiMarino AJ, Cohen S: Abstract: Utility of twenty-four hour esophageal pH monitoring in patients with persistent symptoms on PPI therapy. Gastroenterology 126(132):A-19, 2004","journal-title":"Gastroenterology"},{"key":"2960_CR25","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0889-8553(02)00037-7","volume":"31","author":"J Steinbach","year":"2002","unstructured":"Steinbach J, Fass R, Mittal R: Assessment of relationship between acid reflux and heartburn suing receiver operating characteristics curves. Gastroenterol Clin North Am 31:S35\u2013S58, 2002","journal-title":"Gastroenterol Clin North Am"},{"key":"2960_CR26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004836-200210000-00003","volume":"35","author":"PO Katz","year":"2002","unstructured":"Katz PO: Editorial: Diagnosis and therapy of noncardiac chest pain: a clinical dilemma. J Clin Gastroenterol 35:292\u2013294, 2002","journal-title":"J Clin Gastroenterol"},{"key":"2960_CR27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1365-2036.2000.00733.x","volume":"14","author":"R Fass","year":"2000","unstructured":"Fass R, Ofman J, Sampliner RE, Camargo L, Wendel C, Fennerty MB: The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive esophagitis. Aliment Pharmacol Ther 14:389\u2013396, 2000","journal-title":"Aliment Pharmacol Ther"},{"key":"2960_CR28","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3109\/00365529709011211","volume":"32","author":"TL Venables","year":"1997","unstructured":"Venables TL, Newland RD, Patel AC, Hole J, Wilcock C, Tubitt ML: Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 32:965\u2013973, 1997","journal-title":"Scand J Gastroenterol"},{"key":"2960_CR29","first-page":"1735","volume":"86","author":"ML Cloud","year":"1991","unstructured":"Cloud ML, Offen WW, Robinson M: Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study. Am J Gastroenterol 86:1735\u20131742, 1991","journal-title":"Am J Gastroenterol"},{"key":"2960_CR30","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1001\/archinte.1991.00400120040007","volume":"151","author":"SM Sabesin","year":"1991","unstructured":"Sabesin SM, Berline RG, Humphries TJ, Bradstreet DC, Walton-Bowen KL, Zaidi S: Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group. Arch Intern Med 151:2394\u20132400, 1991","journal-title":"Arch Intern Med"},{"key":"2960_CR31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1572-0241.1999.00777.x","volume":"94","author":"PJ Kahrilas","year":"1999","unstructured":"Kahrilas PJ, Fennerty MB, Joelsson B: High- versus standard dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial. Am J Gastroenterol 94:92\u201397, 1999","journal-title":"Am J Gastroenterol"},{"key":"2960_CR32","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1046\/j.1365-2036.2000.00882.x","volume":"14","author":"R Fass","year":"2000","unstructured":"Fass R, Murthy U, Hayden CW, Malagon IB, Pulliam G, Wendel C, Kovacs TO: Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy\u2014a prospective, randomized, multi-centre study. Aliment Pharmacol Ther 14:1595\u20131603, 2000","journal-title":"Aliment Pharmacol Ther"},{"key":"2960_CR33","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/gut.51.6.885","volume":"51","author":"R Fass","year":"2002","unstructured":"Fass R, Tougas G: Functional heartburn: the stimulus, the pain, and the brain. Gut 51:885\u2013892, 2002","journal-title":"Gut"},{"key":"2960_CR34","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1572-0241.2002.05532.x","volume":"97","author":"DO Castell","year":"2002","unstructured":"Castell DO, Kahrilas PJ, Richter JE, Vakil NB, Johnson DA, Zuckerman S, Skammer W, Levine JG: Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 97:575\u2013583, 2002","journal-title":"Am J Gastroenterol"},{"key":"2960_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1365-2036.1999.00438.x","volume":"13","author":"CP Dekkers","year":"1999","unstructured":"Dekkers CP, Beker JA, Thjodleifsson B, Gabryelewicz A, Bell NE, Humphries TJ: Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group. Aliment Pharmacol Ther 13:49\u201357, 1999","journal-title":"Aliment Pharmacol Ther"},{"key":"2960_CR36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2036.1995.tb00388.x","volume":"9","author":"J Mossner","year":"1995","unstructured":"Mossner J, Holscher AH, Herz R, Schneider A: A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial. Aliment Pharmacol Ther 9:321\u2013326, 1995","journal-title":"Aliment Pharmacol Ther"},{"key":"2960_CR37","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1365-2036.2000.00856.x","volume":"14","author":"PJ Kahrilas","year":"2000","unstructured":"Kahrilas PJ, Falk GW, Johnson DA, Schmitt C, Collins DW, Whipple J, D'Amico D, Hamelin B, Joelsson B: Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators. Aliment Pharmacol Ther 14:1249\u20131258, 2000","journal-title":"Aliment Pharmacol Ther"},{"key":"2960_CR38","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1542-3565(04)00288-5","volume":"2","author":"BB Dean","year":"2004","unstructured":"Dean BB, Gano A, Jr, Knight K, Ofman J, Fass R: Effectiveness of proton pump inhibitors in non-erosive reflux disease (NERD). Clin Gastroenterol Hepatol 2:656\u2013664, 2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2960_CR39","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/00365529709011212","volume":"32","author":"T Lind","year":"1997","unstructured":"Lind T, Havelund T, Carlsson R: Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 32:974\u2013979, 1997","journal-title":"Scand J Gastroenterol"},{"key":"2960_CR40","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0022-5223(19)37879-1","volume":"79","author":"TR DeMeester","year":"1980","unstructured":"DeMeester TR, Wang CI, Wenly JA, Pellegrini CA, Little AG, Klementschitsch P, Bermudez G, Johnson LF, Skinner DB: Technique, indications, and clinical use of 24 hr esophageal pH monitoring. J Thorac Cardiovasc Surg 79:656\u2013670, 1980","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2960_CR41","first-page":"1997","volume":"92","author":"BE Schenk","year":"1997","unstructured":"Schenk BE, Juipers EJ, Klinkenberg-Knol EC, Festen HP, Jansen EH, Tuynman HA, Schrijver M, Dieleman LA, Meuwissen SG: Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 92:1997\u20132000, 1997","journal-title":"Am J Gastroenterol"},{"key":"2960_CR42","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/BF02212678","volume":"40","author":"KC Trimble","year":"1995","unstructured":"Trimble KC, Farouk R, Pryde A, Douglas S, Heading RC: Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci 40:1607\u20131613, 1995","journal-title":"Dig Dis Sci"},{"key":"2960_CR43","doi-asserted-by":"crossref","first-page":"G743","DOI":"10.1152\/ajpgi.2001.281.3.G743","volume":"281","author":"N Pehlivanov","year":"2001","unstructured":"Pehlivanov N, Liu J, Mittal R: Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Physiol Gastrointest Liver Physiol 281:G743\u2013G751, 2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2960_CR44","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1572-0241.2004.04171.x","volume":"99","author":"J Tack","year":"2004","unstructured":"Tack J, Koek G, Demedts I, Sifrim D, Janssens J: Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: reflux, bile reflux, or both? Am J Gastroenterol 99:981\u2013990, 2004","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2960-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-005-2960-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2960-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T02:32:48Z","timestamp":1626575568000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-005-2960-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["2960"],"URL":"https:\/\/doi.org\/10.1007\/s10620-005-2960-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}